Singapore Medical Group hits all-time high

Published Thu, Aug 11, 2016 · 09:50 PM

Singapore

SINGAPORE Medical Group (SMG) on Thursday rose S$0.055 Singapore cents or 20.4 per cent to S$0.325 - an all-time high. With more than 53 million shares changing hands, it was the third most active counter after Noble Group and Ezra Holdings.

This came after RHB initiated coverage on the specialist healthcare provider with a "buy" rating and a target price of S$0.45 on Thursday, but also following recent announcements that it was boosting its ownership in its associated company, Lifescan Imaging, to 100 per cent.

This, it said, would give the group an additional net profit of S$348,000 for the six months ended June 30, 2016. Last week, it also announced that it had returned to the black, with a net profit of S$633,000 and a 33.5 per cent increase in revenue to S$19.5 million for the first half of the year.

Meanwhile, RHB's initiation report painted an optimistic picture of the company, saying that with its turnaround now "concrete" (it was facing debt and legal woes a couple years ago), its prospects are bright, driven by several factors. These include a change in doctors' remuneration, higher operational efficiencies and a patient load that will continue to boost its utilisation rate and margins. The change in doctors' remuneration to a more variable component has attracted more top-notch specialists and increased the retention rate of revenue-generating performing specialists, RHB said.

Other reasons to be bullish on the stock include contributions from the expansion of its new diagnostics business, and potential mergers and acquisitions of private clinics trading at lower multiples.

The new diagnostics business has tremendous potential, said the brokerage. SMG's management sees great potential and synergies in the imaging diagnostics business and has made a few acquisitions in this sector. Currently, it has three diagnostics centres in Paragon and Novena. It is likely to continue to invest more in this segment, possibly with new acquisitions and by adding machines to increase its capacity.

RHB added that SMG is currently trading at an "undemanding" 22 times FY17 price-earnings ratio - which is at deep discounts of 38 per cent and 44 per cent to its local and foreign peers respectively.

SMG's share price has more than doubled in the last three weeks, prompting a query from the Singapore Exchange on July 29.